Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Insulin Articles
Popular Insulin Articles
Highly Recommended Insulin Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
New Drug for Type 2 Diabetes Shows No Liver Damage
In clinical trials, patients taking ACTOS demonstrated no elevation of their liver enzymes when compared to patients taking a placebo.
ACTOS, also known as pioglitazone, helps restore the body's ability to use its own insulin by reducing insulin resistance in people with type 2 diabetes.
More than 4,500 people worldwide have taken part in trials for ACTOS. Efficacy and safety data from trials involving 2,600 patients in the United States were recently submitted to the Food and Drug Administration (FDA) for review. Data presented to the FDA showed that elevated liver enzymes occurred in less than 1 percent of ACTOS-treated patients. Those treated with a placebo had similar results.
Comparing Rezulin and ACTOS, James W. Freston, MD, PhD, professor and director of the Office of Clinical Research, University of Connecticut Health Care, says, "This indicates the liver toxicity seen with another drug in this class is unique to that drug and may not reflect a class effect."
Side effects associated with ACTOS at clinical trials included mild upper respiratory tract infection, headache, sinusitis, muscle pain, tooth disorder and inflammation of the pharynx.
Takeda, the Japanese company that manufactures ACTOS, filed a new drug application with the FDA in January. If approved, ACTOS would be used as a stand-alone therapy, or in combination with sulfonylureas, metformin or insulin for the treatment of type 2 diabetes.
The FDA granted priority review status to ACTOS in March.
Categories: Actos, Diabetes, Food, Insulin, Type 2 Issues, Type 2 Medications
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...